FDA Drug Approval Process (Rebroadcast)
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA's accelerated approval process to treat serious and life threatening diseases.
science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
a medical oncologist affiliated with Suburban Hospital in Bethesda.
former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
This is a rebroadcast. Please view the original broadcast to comment.